9th International mRNA Health Conference

Nadia Luheshi

As an Associate Director in the Oncology R&D Unit at AstraZeneca, Nadia Luheshi leads research to discover and develop novel immuno-oncology therapies, including IL-12 mRNA (MEDI1191), which is now being evaluated in a phase I clinical trial. Her research group at AZ also has a particular focus on understanding the role of the myeloid cells in the tumour microenvironment in regulating anti-tumour immunity. Before she joined AstraZeneca 9 years ago, her PhD and post-doctoral research at the University of Manchester explored the innate immune response to tissue injury.

bannermrnaaa

Agenda

The entire program of the mRNA Conference

My Agenda

Add lectures with the ★ to "My Agenda" and create your personal program for the conference

Speakers

See all speakers of the mRNA Conference

Sponsors

Find out about all the sponsors of the mRNA conference.

Attendees

Search for your participating colleagues and get in touch with them

Contact Exchange

Exchange your contact details with other attendees of the conference

Messages

Use the messenger to chat with your colleagues

Contact QR Code

Your QR Code for the selfprint station and admission control

Twitter

Stay up to date and follow mRNA Conference on twitter

News

All important news of the mRNA Conference

Info

Important information regarding the mRNA Conference

My Photo

Add a photo to your account

Data Consent

Change your data consent at any time

LogOut